MedPath

University of Oxford

University of Oxford logo
🇬🇧United Kingdom
Ownership
Private
Established
1096-01-01
Employees
10K
Market Cap
-
Website
http://www.ox.ac.uk

PLH for Teens - Hybrid Delivery

Not Applicable
Completed
Conditions
Child Maltreatment
Positive Parenting
First Posted Date
2021-10-08
Last Posted Date
2024-05-08
Lead Sponsor
University of Oxford
Target Recruit Count
1128
Registration Number
NCT05071924
Locations
🇬🇧

University of Oxford, Oxford, Oxfordshire, United Kingdom

A Controlled Human Vivax Malaria Infection Study Through Inoculation of Infected Erythrocytes

Not Applicable
Recruiting
Conditions
Plasmodium Vivax Infection
Interventions
Biological: An inoculum of malaria parasitised red blood cells with whole dose blood-stage inoculum
First Posted Date
2021-10-07
Last Posted Date
2024-06-26
Lead Sponsor
University of Oxford
Target Recruit Count
48
Registration Number
NCT05071079
Locations
🇹🇭

Faculty of Tropical Medicine, Bangkok, Thailand

Village Malaria Worker Expansion

Completed
Conditions
Febrile Illness
First Posted Date
2021-09-16
Last Posted Date
2025-03-19
Lead Sponsor
University of Oxford
Target Recruit Count
7191
Registration Number
NCT05045547
Locations
🇰🇭

Action for Health and Development, Battambang, Cambodia

Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV)

Phase 2
Recruiting
Conditions
COVID-19
Interventions
Drug: Nirmatrelvir/ritonavir (e.g. PAXLOVID™)
Drug: Molnupiravir and nirmatrelvir/ritonavir (e.g. PAXLOVID™)
Other: No treatment
Drug: Monoclonal antibodies
Drug: Molnupiravir
First Posted Date
2021-09-13
Last Posted Date
2024-10-28
Lead Sponsor
University of Oxford
Target Recruit Count
3800
Registration Number
NCT05041907
Locations
🇳🇵

Sukraraj Tropical & Infectious Disease Hospital, Kathmandu, Nepal

🇧🇷

Universidade Federal de Minas Gerais, Minas Gerais, Brazil

🇱🇦

Laos-Oxford-Mahosot Wellcome Trust Research Unit, Vientiane, Lao People's Democratic Republic

and more 4 locations

Fenfluramine and Cognition

Phase 4
Completed
Conditions
Cognitive Function
Interventions
Other: Placebo
First Posted Date
2021-08-30
Last Posted Date
2022-11-15
Lead Sponsor
University of Oxford
Target Recruit Count
56
Registration Number
NCT05026398
Locations
🇬🇧

Department of Psychiatry, University of Oxford, Oxford, United Kingdom

Sedation, ANalgesia and Delirium MANagement in Intensive Care Unit

Completed
Conditions
Critical Illness
Covid19
Intensive Care Unit Delirium
Sedation Complication
Analgesia
Interventions
Other: No intervention
First Posted Date
2021-08-30
Last Posted Date
2023-06-06
Lead Sponsor
University of Oxford
Target Recruit Count
3421
Registration Number
NCT05027217
Locations
🇬🇧

University of Oxford, Oxford, United Kingdom

Overcoming Gait Freeze in Parkinson's Disease Using Responsive Cueing

Not Applicable
Completed
Conditions
Parkinson's Disease
Interventions
Device: Rhythmic vibration cueing (lower leg)
First Posted Date
2021-08-24
Last Posted Date
2021-08-24
Lead Sponsor
University of Oxford
Target Recruit Count
17
Registration Number
NCT05019469
Locations
🇬🇧

The Bosworth Clinic, Cassington, Oxfordshire, United Kingdom

Manipulating and Optimising Brain Rhythms for Enhancement of Sleep

Not Applicable
Completed
Conditions
Chronic Pain
Parkinson Disease
MSA - Multiple System Atrophy
Epilepsy
Interventions
Device: Deep brain stimulation
First Posted Date
2021-08-18
Last Posted Date
2022-11-04
Lead Sponsor
University of Oxford
Target Recruit Count
4
Registration Number
NCT05011773
Locations
🇬🇧

John Radcliffe Hospital, Oxford, Oxfordshire, United Kingdom

ParentText User Engagement and Effectiveness Study

Not Applicable
Terminated
Conditions
Engagement
Intimate Partner Violence
Child Maltreatment
Positive Parenting
Interventions
Behavioral: ParentText
First Posted Date
2021-08-12
Last Posted Date
2024-05-01
Lead Sponsor
University of Oxford
Target Recruit Count
1400
Registration Number
NCT05003518
Locations
🇲🇾

Family and Child Ecology at the Department of Human Development and Family Studies, Putrajaya, Putraja, Malaysia

Tafenoquine and Primaquine in Colostrum and Breast Milk

Phase 4
Withdrawn
Conditions
Healthy Lactating Women
Interventions
First Posted Date
2021-08-02
Last Posted Date
2024-04-04
Lead Sponsor
University of Oxford
Registration Number
NCT04984759
Locations
🇹🇭

Shoklo Malaria Research Unit (SMRU), Mae Sot, Tak, Thailand

© Copyright 2025. All Rights Reserved by MedPath